- Home
- ENB vs MCK Comparison
ENB vs MCK Comparison
Compare ENB & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENB
- MCK
- Stock Information
- Founded
- ENB 1949
- MCK 1833
- Country
- ENB Canada
- MCK United States
- Employees
- ENB N/A
- MCK N/A
- Industry
- ENB Natural Gas Distribution
- MCK Other Pharmaceuticals
- Sector
- ENB Energy
- MCK Health Care
- Exchange
- ENB Nasdaq
- MCK Nasdaq
- Market Cap
- ENB 99.9B
- MCK 88.5B
- IPO Year
- ENB N/A
- MCK N/A
- Fundamental
- Price
- ENB $48.36
- MCK $686.45
- Analyst Decision
- ENB Strong Buy
- MCK Strong Buy
- Analyst Count
- ENB 2
- MCK 9
- Target Price
- ENB $60.50
- MCK $735.67
- AVG Volume (30 Days)
- ENB 3.9M
- MCK 980.2K
- Earning Date
- ENB 08-01-2025
- MCK 08-06-2025
- Dividend Yield
- ENB 5.53%
- MCK 0.48%
- EPS Growth
- ENB 8.96
- MCK 11.87
- EPS
- ENB 2.09
- MCK 24.95
- Revenue
- ENB $47,275,380,146.00
- MCK $377,595,000,000.00
- Revenue This Year
- ENB $10.76
- MCK $14.70
- Revenue Next Year
- ENB N/A
- MCK $7.77
- P/E Ratio
- ENB $23.11
- MCK $27.52
- Revenue Growth
- ENB 48.17
- MCK 20.35
- 52 Week Low
- ENB $39.30
- MCK $464.42
- 52 Week High
- ENB $48.59
- MCK $737.89
- Technical
- Relative Strength Index (RSI)
- ENB 64.50
- MCK 48.48
- Support Level
- ENB $47.09
- MCK $677.28
- Resistance Level
- ENB $48.29
- MCK $686.27
- Average True Range (ATR)
- ENB 0.60
- MCK 13.98
- MACD
- ENB -0.00
- MCK 1.64
- Stochastic Oscillator
- ENB 89.04
- MCK 68.20
About ENB Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the us and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. The firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
About MCK McKesson Corporation
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.